Significance of the prognostic stratification of extranodal extension in colorectal cancer
We have to thank Huang and Yang for their very interesting letter [1] , in which they comment a recent meta-analysis of our group of research [2] , as well as a subsequent letter on the same topic [3] . We recognize as important points those highlighted by Huang et al., particularly when they pointed out that colon and rectal cancer are different in anatomic site, embryological origin, function and also in metastatic patterns. At the same time, we still consider of value the results of our manuscript, in which we present the analysis on the prognostic value of extranodal extension (ENE) of nodal metastasis considering colon and rectal cancer as one entity only. Notably, we have also presented the hazard ratios of a significant number of studies and, in the subsequent letter, we have indicated that the location has not been recognized as a probable moderator of our findings (P = 0.229). The approach to consider colon and rectal cancer together was further justified by the fact that the staging systems do not consider separately such neoplasms. Notably, the prognostic role of ENE has been shown in diverse other cancer types [4, 5] and its importance independently from specific anatomic subdistinctions is further suggested by the case of carcinoma of pancreas versus that of papilla of Vater [5] .
In our meta-analysis and in our letter, we address the prognostic impact of ENE in both colon and rectal cancers, but without suggesting a unique staging system for these two neoplasms. Indeed, we recognize that the current TNM staging system needs improvements, and the inclusion of ENE might be one of these. 
